Potassium Binders
Hyperkalaemia is common in treated HF, especially if on RAAS inhibitor drugs and in the presence of impaired renal function. The signs and/or symptoms of hyperkalaemia include weakness, fatigue, and/or paralysis, nausea and constipation and bradyarrhythmias. ECG changes include peaked T waves, prolo...
Main Authors: | Agnieszka Tycinska, Ewa A Jankowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Barcaray International
2019-01-01
|
Series: | International Cardiovascular Forum Journal |
Subjects: | |
Online Access: | https://icfjournal.org/index.php/icfj/article/view/621/pdf |
Similar Items
-
The Management of Co-Morbidities in Patients with Heart Failure – Potassium Balance
by: Ewa A Jankowska
Published: (2017-01-01) -
Interactive effects of potassium, acidosis, catecholamines and calcium on the heart
by: Leitch, Stewart Paul
Published: (1994) -
Impact of Dietary Potassium Restrictions in CKD on Clinical Outcomes: Benefits of a Plant-Based Diet
by: Deborah J. Clegg, et al.
Published: (2020-07-01) -
Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis
by: Dhan Bahadur Shrestha, MD Resident Physician, et al.
Published: (2021-01-01) -
Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
by: Joseph B. Muhlestein, et al.
Published: (2021-02-01)